This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Julia Kaufman and a Patent for Systemic Sclerosis Treatment
Introduction
Julia Kaufman is an inventor associated with Eastchester, New York, and Boehringer Ingelheim International GmbH. Her listed patent concerns a potential treatment approach for systemic sclerosis.
Latest Patents
Kaufman is credited with 1 patent: “Soluble Guanylate Cyclase Activators for Treating Systemic Sclerosis.” The invention describes methods for treating patients with systemic sclerosis by administering a therapeutically effective amount of a soluble guanylate cyclase (sGC) activator of formula (I), or a pharmaceutically acceptable salt thereof. The patent abstract specifies that the substituents and groups are defined in the patent.
Career Highlights
The available information connects Kaufman’s patent work with Boehringer Ingelheim International GmbH. The invention focuses on a pharmaceutical approach to systemic sclerosis, a serious disease for which new treatment strategies are an important area of medical research.
Collaborations
Kaufman’s listed coworkers include Mary Ruth Flack and Indra Sethy-Coraci. The provided information does not specify their individual roles in the patent or the extent of their collaboration.
Conclusion
Julia Kaufman’s listed patent reflects research into soluble guanylate cyclase activators as a potential treatment strategy for systemic sclerosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile